Search

everythinglearnresearchcommunity

for

Search:↓

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Ayurvedic treatment helped reduce PCOS symptoms in a 19-year-old girl.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The woman's hair loss is likely stress-related and should improve without treatment.

Red light exposure can slow aging in mice by improving fat metabolism.

GLP-1RA therapy may increase the risk of hair loss.

SesZen-Bio™ may be a promising and safer option for promoting hair growth.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

Psoriasis worsens in winter in India due to less sunlight and dry skin, needing personalized treatment.

PRP can reduce pain and improve function, but more standardized research is needed.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.

Bariatric surgery patients need careful before and after surgery care for safety and long-term health.

Accurate diagnosis and treatment of skin and hair disorders are crucial, with growing focus on hair loss treatments like topical minoxidil.

Noggin overexpression delays eyelid opening by affecting cell death and skin cell development.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Low prolactin in young women may increase heart and metabolism risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.